Table 2 Clinicopathological characteristics of patients with colon cancer
From: Synergistic potential of CDH3 in targeting CRC metastasis and enhancing immunotherapy
Features | Categories | Frequency | Percent |
|---|---|---|---|
Sex | Male | 54 | 45.0 |
Female | 66 | 55.0 | |
Age(years) | ≤ 60 | 49 | 40.8 |
>60 | 71 | 59.2 | |
Family history | No | 54 | 81.8 |
Yes | 12 | 18.2 | |
Low + Medium | 62 | 51.7 | |
Invasion depth | Inside muscular | 16 | 13.3 |
Outside muscular | 42 | 35.0 | |
Lymphatic metastasis | Yes | 20 | 28.6 |
No | 50 | 71.4 | |
CEA | Negative | 57 | 64.8 |
Positive | 31 | 35.2 | |
CA-125 | Negative | 58 | 76.3 |
Positive | 18 | 23.7 | |
CA19-9 | Negative | 67 | 80.7 |
Positive | 16 | 19.3 |